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and indivi duals who became pregnant were questioned about the time to first pregnancy.
Barton and co-workers found that 16% of the cancer survivors experienced total infertility.
1 Clinical infertility was reported in 13% of the survivors, of whom 64% went on to conceive. The data suggest that some survivors of childhood cancer can have a family; however, the researchers found that cancer survivors experienced longer times to pregnancy than the sibling con trol group. Furthermore, the re searchers found that radiotherapy and exposure to alkylating agents were associated with a significantly increased risk of infertility in cancer su rvivors compared with the sibling control group.
The results from the Barton study challenge the scientific and medical community to identify those patients who are at greatest risk of fertility issues, not only by taking into account the potential effect of a particular treatment regimen, but also by assessing the fertility potential in survivors. No marker exists that predicts fertility (measured as a successful, intended and timely pregnancy) in young adults, let alone in children and adolescents. The birth of a child ultimately depends on the ovarian reserve, the health and integrity of the uterus as well as the quality of the sperm. The number of follicles within an ovary is an index of the length and quality of a woman's fertility-the ovarian reserve. 4 The anti-Müllerian hormone, which is derived from the follicles, is currently the only quantitative marker of the ovarian reserve. 4 An ideal fertility marker would correlate with the 'predicted' ovarian reserve so that children with different numbers of ovarian follicles can be identified and the follicular content could be monitored more frequently after cancer treatment to determine an approximate time to menopause. Yet, even a good marker of the ovarian follicle reserve might not measure the quality of the oocytes after cancer treatment; such a marker would be highly informative, both to cancer survivors and any woman interested in the length of her reproductive lifespan. The search for a marker of oocyte quality is an active area of research.
Removing an ovary, even when sterility is almost certain, is a very difficult decision. Advances in ovarian tissue transplantation have resulted in restoration of puberty in one prepubertal cancer patient and fertility in some young adults.
5, 6 Whereas these results are good news for all cancer patients, the reintroduction of cancer from the transplanted tissue is a risk. 7 Strategies to protect fertility by blocking the effects of radiation and chemotherapy outside of the target site are also being studied. Gonadotropinreleasing hormone analogues, 8 imatinib 9 and other ovarian and follicle protective treatments represent future fertility preservation strategies, although follow-up studies are needed to determine their long-term efficacy. Targeted biologics that do not harm the oocyte would be the ultimate approach to reduce cancer-related infertility, and current global scientific efforts are focused on finding such treatment solutions.
One of the more worrisome findings in the Barton et al. study is that, although the probability of seeking infertility care was similar between cancer survivors and their sibling controls, cancer survivors were less likely to receive treatment. Physicians might be reluctant to refer cancer survivors to traditional infertility care, which suggests that both patients and doctors need to be informed about the value of assisted reproductive technologies. In the past, cancer survivors were also less likely to be referred to adoptive or surrogate services, and many adoption agencies denied female cancer survivors the opportunity to adopt. However, this behaviour is now changing.
The CCSS has been one of the most impor tant studies to comprehensively assess a range of reproductive, endocrine, psychological and behavioural outcomes among a large cohort of childhood cancer survivors. 10 The CCSS has provided physicians with treatment recom mendations and has led to the develop ment of patient decision aids. The study by Barton and colleagues gives us a good understanding of the risk of infertility in adults who survive childhood cancer and serves as a clarion call to the research community to keep working on ways to reduce this risk. 
DIABETES
The search for mechanisms underlying bariatric surgery
Rohit Kohli and Randy J. Seeley
Bariatric surgery is an effective weight-loss strategy and often results in remission of type 2 diabetes mellitus (T2DM); still, how this surgery affects T2DM is unknown. A new study suggests that fibroblast growth factor 19 and bile acids are involved in remission of T2DM after bariatric surgery. 
NEWS & VIEWS
tract, it has become clear that a small gastric pouch and/or reduced calorie absorption from the intestine cannot fully explain either weight loss or remission of type 2 diabetes mellitus (T2DM) following bariatric surgery. This finding has led to a growing research effort to identify the underlying physiological mechanisms that account for the metabolic improvement in patients who undergo bari atric surgery. Gerhard et al.
2 provide insights into one potential mechanism behind the metabolic benefits following RYGB that are unrelated to weight loss. This study shows that among patients who underwent RYGB, those with sustained remission of T2DM had the greatest increase in serum levels of bile acids and an ileal-derived hormone, fi broblast growth factor 19 (FGF-19).
Increased serum levels of bile acids after RYGB have been reported by multiple research groups over the past 5 years. [3] [4] In 2009, one research group found that the levels of specific types of bile acids, such as cholic acid, deoxycholic acid and chenodeoxy cholic acid, were increased after RYGB. 5 Other studies also showed that serum levels of cholic acid are raised in indivi duals who have undergone RYGB surgery but not in individuals who have undergone other types of bariatric surgery, such as adjustable gas tric banding. 6 Gerhard et al. confirmed previous results and found that the same three specific types of bile acids show the greatest increase in patients with sustained remission of T2DM after RYGB surgery.
An important aspect of bile acid phy siology is that endocrine FGFs act as hormones rather than growth factors; FGF-19 is produced in the ileum and acts on both the liver and the gallbladder to regulate produc tion and secretion of bile acids. 6 Gerhard et al. show that patients with the most successful results in terms of sustained remission of T2DM were the ones with the greatest increase in serum levels of FGF-19 and bile acids.
2 Although RYGB raises the levels of FGF-19 and bile acids, these increases are not seen after every type of bariatric surgery or in BMI-matched control individuals who have not undergone bariatric surgery.
5 For example, adjustable gastric banding does not lead to altered levels of gut hormones or increased serum levels of bile acids even though patients generally lose weight. 7, 6 Gerhard et al. presents important evidence in humans for a link between alterations in the bile acid-FGF-19 axis after bariatric surgery and improvement of T2DM.
The study by Gerhard et al. provides a framework for further experiments that can directly test the mechanisms behind these observations. A large body of literature has described the endocrine changes that occur in humans as a result of RYGB; however, this surgery is difficult to replicate in animal models. The lack of experimental systems to test molecular targets has greatly slowed the pace of our understanding of the metabolic changes that occur following bariatric surgery. However, data from rats published in 2013 support the contention that direct manipulation of the flow of bile acids can produce considerable metabolic improvements. 8, 9 Diverting the flow of bile acids to the mid-jejunum in rats leads to increased plasma levels of bile acids, improved glucose tolerance and increased secretion of g lucagon-like peptide 1. 8, 9 However, important questions remain, such as how RYGB results in changes in plasma levels of bile acids. Increased levels of FGF-19 result in a negative feedback loop, which leads to suppression of hepatic synthesis of bile acids. 10 To explain how individuals can have raised serum levels of both bile acids and FGF-19, we hypo thesize that patients with T2DM, who have increased hepatic insulin resistance, have decreased uptake of bile acids by liver cells. If true, this discrepancy could also explain why Gerhard et al. did not see a change in the levels of enzymes involved in synthesizing bile acids (such as cholesterol 7-α-monooxygenase) in patients without T2DM undergoing RYGB.
Another key issue is the association between the bile acid-FGF-19 axis and fatty liver disease. In the study by Gerhard and co-workers, experienced pathologists used biopsy samples taken during surgery to determine whether each patient had fatty liver disease and the disease stage where rele vant. Unfortunately, without post opera tive liver biopsy samples, one cannot con trast changes in liver histology with the obser ved changes in body weight or corre late them with the changes identified in bile acid-FGF-19 physiology in this report. There fore, this approach is inherently limited and makes the results difficult to interpret. Fur ther studies are needed to relate the changes in the levels of bile acids and FGF-19 to direct measurements of liver histology and function. Gerhard and colleagues have identified an important association between bile acids and the metabolic improvements that occur after RYGB surgery. This work will pave the way to identify the specific molecular targets that mediate the effects of RYGB and other effective bariatric procedures. A detailed understanding of the molecular mechanisms that are affected by bariatric surgery is key to improving the use of these procedures. Patients who are most likely to respond to a particular therapy could then be identified, and less invasive therapies than RYGB could be designed on the basis of these mechanism s to treat patients with T2DM.
